Status:
ACTIVE_NOT_RECRUITING
SKY Breath Intervention
Lead Sponsor:
University of California, San Francisco
Conditions:
Depression
Anxiety Disorders
Eligibility:
All Genders
16-24 years
Brief Summary
Depression is highly debilitating and prevalent among adolescents. Adolescent-onset depression is associated with long, severe, and recurrent episodes that are often not responsive to treatment. There...
Detailed Description
Participants \& Screening: All participants (16-24yrs) will be first screened for COVID and only those who are negative will be allowed to enroll. Participants who meet the criteria for the study at i...
Eligibility Criteria
Inclusion
- adolescent participants ages 16-24 yrs old (NIH defines adolescents as up through age 24 years old)
- mild-to-moderate depression with the BDI-II score greater than or equal to 14 (Smarr and Keefer 2011)
- technologically able (Zoom);
- nonpractitioners of daily meditation/breath-work.
Exclusion
- pregnant or lactating females
- metal implants unsafe for MRI
- current or lifetime diagnosis of schizophrenia, schizoaffective, bipolar on lithium, or seizure disorders
- recent surgical patient (within 6 months)
- substance use disorder within the last 1 year
- history of significant medical conditions (e.g. traumatic brain injury)
- suicidal ideation (SI) with intent and/or plan to harm self (SI without intent and/or plan to harm self will be allowed to enter the study)
Key Trial Info
Start Date :
April 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05388110
Start Date
April 22 2022
End Date
December 1 2028
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143